These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1972199)

  • 1. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography.
    Simon J; Benyhe S; Hepp J; Varga E; Medzihradszky K; Borsodi A; Wollemann M
    J Neurosci Res; 1990 Apr; 25(4):549-55. PubMed ID: 1972199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Hepp J; Khan A; Borsodi A; Szücs M; Medzihradszky K; Wollemann M
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brain.
    Borsodi A; Khan A; Simon J; Benyhe S; Hepp J; Wollemann M; Medzihradszky K
    NIDA Res Monogr; 1986; 75():1-4. PubMed ID: 2828951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM; Traynor JR
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
    Hjorth SA; Thirstrup K; Schwartz TW
    Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 125I-DPDYN, monoiodo [D-Pro10]- dynorphin (1-11), is an effective and useful tool for the study of kappa opioid receptors.
    Gairin JE; Jomary C; Cros J; Meunier JC
    NIDA Res Monogr; 1986; 75():232-5. PubMed ID: 2893266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
    Zawilska J; Lajtha A; Borsodi A
    Acta Biochim Biophys Hung; 1989; 24(1-2):33-9. PubMed ID: 2575315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
    Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
    Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dynorphin1-8 binding sites in frog (Rana esculenta) brain membranes.
    Benyhe S; Simon J; Borsodi A; Wollemann M; Barnard EA
    Neuropeptides; 1994 May; 26(5):359-64. PubMed ID: 7915022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
    Dumont M; Lemaire S
    J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization, solubilization and purification of an opioid receptor from the brain of the frog Rana ridibunda.
    Pascaud A; Mollereau C; Puget A; Baillat G; Mazarguil H; Meunier JC
    NIDA Res Monogr; 1986; 75():5-8. PubMed ID: 2828997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of dynorphin A and related peptides with cardiac ouabain binding sites.
    Dumont M; Lemaire S
    J Mol Cell Cardiol; 1996 Mar; 28(3):615-21. PubMed ID: 9011644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.
    Zhang S; Tong Y; Tian M; Dehaven RN; Cortesburgos L; Mansson E; Simonin F; Kieffer B; Yu L
    J Pharmacol Exp Ther; 1998 Jul; 286(1):136-41. PubMed ID: 9655852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
    Paterlini G; Portoghese PS; Ferguson DM
    J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.